NCT03986268View on ClinicalTrials.gov

Vitamin D Can Increase Pathological Response of the Breast Cancer Patients Treated With Neoadjuvant Therapy

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

December 10, 2020

Study Completion Date

December 10, 2020

Conditions
Vitamin D DeficiencyChemotherapy EffectPathology
Interventions
DRUG

Vit D

The aim of this study is investigating pathologic response to neoadjuvant therapy if we give replacement therapy with vitamin D3 50.000 IU weekly dosage concurrent with chemotherapy in breast cancer patients.

Trial Locations (1)

34450

İstanbul Florence Nightingale Hospital Breast Health Center, Istanbul

All Listed Sponsors
lead

Florence Nightingale Hospital, Istanbul

OTHER

NCT03986268 - Vitamin D Can Increase Pathological Response of the Breast Cancer Patients Treated With Neoadjuvant Therapy | Biotech Hunter | Biotech Hunter